These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1354919)

  • 21. Abecarnil shows reduced tolerance development and dependence potential in comparison to diazepam: animal studies.
    Löscher W
    Psychopharmacol Ser; 1993; 11():96-112. PubMed ID: 7908436
    [No Abstract]   [Full Text] [Related]  

  • 22. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
    Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
    J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benzodiazepine, beta-carboline, and barbiturate actions on GABA responses.
    Macdonald RL; Weddle MG; Gross RA
    Adv Biochem Psychopharmacol; 1986; 41():67-78. PubMed ID: 2874695
    [No Abstract]   [Full Text] [Related]  

  • 24. Bidirectional modulation of GABA function by beta-carbolines.
    Jensen LH; Petersen EN; Honoré T; Drejer J
    Adv Biochem Psychopharmacol; 1986; 41():79-89. PubMed ID: 2874696
    [No Abstract]   [Full Text] [Related]  

  • 25. Difference in learning and retention by Albino-Swiss mice. Part 2. Effect of some anxiolytic drugs.
    Valzelli L; Tomasíková S
    Methods Find Exp Clin Pharmacol; 1985 Nov; 7(11):569-72. PubMed ID: 2868160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
    Small GW; Bystritsky A
    J Clin Psychiatry; 1997; 58 Suppl 11():24-9. PubMed ID: 9363045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discriminative stimulus properties of benzodiazepines and several new anxiolytics.
    Young R
    NIDA Res Monogr; 1991; (116):117-30. PubMed ID: 1369663
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pharmacodynamics of benzodiazepines].
    Puech AJ; Landragin L
    Nouv Presse Med; 1982 Oct; 11(40):2953-5. PubMed ID: 6128718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Midazolam-ethanol interactions and reversal with a benzodiazepine antagonist.
    Van Gorder PN; Hoffman WE; Baughman V; Albrecht RF; Miletich DJ; Guzman F; Cook JM
    Anesth Analg; 1985 Feb; 64(2):129-35. PubMed ID: 2857540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pharmacology of new anxiolytics acting on 5-HT neurones.
    Marsden CA
    Postgrad Med J; 1990; 66 Suppl 2():S2-6. PubMed ID: 1975437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    Lydiard RB; Ballenger JC; Rickels K
    J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A game with shifting mirrors.
    Izquierdo I
    Trends Pharmacol Sci; 1989 Dec; 10(12):473-6. PubMed ID: 2575813
    [No Abstract]   [Full Text] [Related]  

  • 33. Structure activity relationships of anxiolytics.
    Wong MG
    Drug Des Deliv; 1988 Jul; 3(1):15-33. PubMed ID: 2908225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The benzodiazepine story.
    Sternbach LH
    Prog Drug Res; 1978; 22():229-66. PubMed ID: 30117
    [No Abstract]   [Full Text] [Related]  

  • 35. Selective anxiolysis produced by ocinaplon, a GABA(A) receptor modulator.
    Lippa A; Czobor P; Stark J; Beer B; Kostakis E; Gravielle M; Bandyopadhyay S; Russek SJ; Gibbs TT; Farb DH; Skolnick P
    Proc Natl Acad Sci U S A; 2005 May; 102(20):7380-5. PubMed ID: 15870187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of several benzodiazepine receptor ligands in two models of anxiolytic activity in the mouse: an analysis based on fractional receptor occupancies.
    Jones GH; Schneider C; Schneider HH; Seidler J; Cole BJ; Stephens DN
    Psychopharmacology (Berl); 1994 Mar; 114(2):191-9. PubMed ID: 7838907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What are the differences between abecarnil and conventional benzodiazepine anxiolytics?
    Stephens DN; Turski L; Hillman M; Turner JD; Schneider HH; Yamaguchi M
    Adv Biochem Psychopharmacol; 1992; 47():395-405. PubMed ID: 1354919
    [No Abstract]   [Full Text] [Related]  

  • 38. Modulation of basal and stress-induced release of acetylcholine and dopamine in rat brain by abecarnil and imidazenil, two anxioselective gamma-aminobutyric acidA receptor modulators.
    Dazzi L; Motzo C; Imperato A; Serra M; Gessa GL; Biggio G
    J Pharmacol Exp Ther; 1995 Apr; 273(1):241-7. PubMed ID: 7714771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The discriminative stimulus effects of abecarnil.
    Ator NA; Griffiths RR
    NIDA Res Monogr; 1990; 105():325. PubMed ID: 1678865
    [No Abstract]   [Full Text] [Related]  

  • 40. Anxiolytic and anxiogenic beta-carbolines: tools for the study of anxiety mechanisms.
    Stephens DN; Kehr W; Duka T
    Adv Biochem Psychopharmacol; 1986; 41():91-106. PubMed ID: 2874697
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.